Lesego, Abaleng
Were, Lawrence P. O.
Tsegaye, Tsion
Idris, Rafiu
Morrison, Linden
Peterson, Tatjana
Elhussein, Sheza
Antonio, Esther
Magwindiri, Godfrey
Dumba, Ivan
Mtambirwa, Cleyland
Madzikwa, Newman
Simbi, Raiva
Ndlovu, Misheck
Achoki, Tom
Article History
Received: 6 March 2023
Accepted: 22 April 2024
First Online: 1 May 2024
Declarations
:
: Ethical approval including the consent procedure for participants was obtained from the Ethics Committee of the MOHCC Department of Research and NATPHARM, Harare Zimbabwe. The conduct and methods of this study adhered to the tenets outlined in the Declaration of Helsinki. Informed consent was obtained from each study participant involved in the study. The data collection protocol ensured that all study participants fully understood the objectives of the study and consented in writing to provide the required information. Before the interview commenced, the participants also consented verbally and confirmed that they had understood the objectives of the study and that they could opt out of the interview at any time without prejudice. No sensitive or personally identifying information was collected regarding the study participants.
: Not applicable.
: RI, LM, TP and SE declare that they are fulltime employees at the Global Fund to Fight AIDs, Tuberculosis and Malaria. EA and GM declare that they are fulltime employees at PricewaterhouseCoopers. ID, CM, NM and RS are fulltime employees at National Pharmaceutical Company of Zimbabwe. The rest of the authors declare that they have no competing interests.